Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH)

Choong-kun Lee; Han Sang Kim; Hye Jin Choi

doi:10.1200/JCO.2022.40.4_suppl.456

YUHSpace

BROWSE

0 326

Cited 0 times in

Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH)

Authors: Choong-kun Lee ; Han Sang Kim ; Hye Jin Choi

Citation: JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4) : 456, 2022-02

Journal Title: JOURNAL OF CLINICAL ONCOLOGY

ISSN: 0732-183X

Issue Date: 2022-02

Full Text: https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.456

DOI: 10.1200/JCO.2022.40.4_suppl.456

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

Yonsei Authors: Kim, Han Sang(김한상) https://orcid.org/0000-0002-6504-9927
Lee, Choong-kun(이충근) https://orcid.org/0000-0001-5151-5096
Choi, Hye Jin(최혜진) https://orcid.org/0000-0001-5917-1400

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/194649

사서에게 알리기

Show full item record Find it @ YMLIB

License

YUHSpace: Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH)

YUHSpace

BROWSE

Browse

Links